James H. Finigan, MD

Make an Appointment
James H. Finigan

James H. Finigan, MD, is a pulmonologist at National Jewish Health. Dr. Finigan serves as Director of The Respiratory Centers of Excellence, Medical Director of the Lung Cancer Screening Program and Respiratory Institute Director for the Office of Research Innovation.

Programs and Services

Specialties & Conditions

Research Areas

  • Cellular and Molecular Biology
  • Inflammation
  • Lung Cell Biology
  • Translational Research

Special Interests

Research Interests

My research focuses on how cells of the lung adhere and how cell-cell junctions are altered during lung injury and repair. This process is relevant to numerous pulmonary diseases including acute lung injury as well as lung cancer initiation and progression.

See More

News & Videos

Education

Education

2000 - 2002
University Hospitals of Cleveland, Resident in Internal Medicine
1995 - 1999
University of Rochester School of Medicine, MD
1989 - 1993
Colgate University, BA, English Literature

Residency

2002 - 2003
University Hospitals of Cleveland, Chief Resident

Fellowship

2003 - 2007
Johns Hopkins University School of Medicine, Pulmonary and Critical Care Fellow

Board Certification

2010: BLS, ACLS, Colorado License
2008: Critical Care Medicine
2007: Pulmonary Medicine
2006: Medical License: Ohio
2003: American Board of Internal Medicine

Professional Memberships

American Association for Cancer Research
American Thoracic Society
Pulmonary Circulation Assembly

Publications

Wilson KC, Kaminsky DA, Michaud G, Sharma S, Nici L, Folz RJ, Barjaktarevic I, Bhakta NR, Cheng G, Chupp GL, Cole A, Dixon AE, Finigan JH, Graham B, Hallstrand TS, Haynes J, Hankinson J, MacIntyre N, Mandel J, McCarthy K, McCormack M, Patil SP, Rosenfeld M, Senitko M, Sethi S, Swenson ER, Stanojevic S, Teodorescu M, Weiner DJ, Wiener RS, Powell CA. Restoring Pulmonary and Sleep Services as the COVID-19 Pandemic Lessens. From an Association of Pulmonary, Critical Care, and Sleep Division Directors and American Thoracic Society-coordinated Task Force. Ann Am Thorac Soc. 2020 Nov;17(11):1343-1351. doi: 10.1513/AnnalsATS.202005-514ST. PubMed PMID: 32663071; PubMed Central PMCID: PMC7640724.

Kern JA, Kim J, Foster DG, Mishra R, Gardner EE, Poirier JT, Rivard C, Yu H, Finigan JH, Dowlati A, Rudin CM, Tan AC. Role of mTOR As an Essential Kinase in SCLC. J Thorac Oncol. 2020 Sep;15(9):1522-1534. doi: 10.1016/j.jtho.2020.05.026. Epub 2020 Jun 26. PubMed PMID: 32599072; PubMed Central PMCID: PMC7483946.

Hospital Affiliations

  • Colorado Acute Long Term Hospital
  • Rose Medical Center
  • St. Joseph Hospital - Denver
  • Swedish Medical Center

Academic Affiliations

Professor, University of Colorado Denver
Assistant Professor, University of Colorado, Division of Pulmonary and Critical Care Medicine

Conflicts of Interest

National Jewish Health physicians and scientists may collaborate with pharmaceutical or other industries to develop medical and scientific breakthroughs or to provide education on trends in quality medical practice and outcomes to physicians and health professionals around the country. National Jewish Health maintains a strict conflict of interest policy to ensure that all potential conflicts are clearly visible and that management plans are put in place in order to further innovation and education while ensuring the protection of our patients and the integrity of our research. National Jewish Health publicly discloses any payment to our physicians or scientists. View this faculty member’s industry relationships and collaborations.

Make an Appointment